Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD
VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the…
Zarminali Pediatrics Welcomes New Chief Technology Officer to Advance Patient-Centric Connected Care Model
CHICAGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics, the first outpatient…
![U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease](https://i3.wp.com/mms.businesswire.com/media/20250905840795/en/1247790/22/Takeda_Red_Logo_2021.jpg?w=420&resize=420,280&ssl=1 "U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease"){kind=logo}
U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce…
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO
SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug…
New Vizient Survey Finds Drug Shortages Cost Hospitals Nearly $900M Annually in Labor Expenses
IRVING, Texas--(BUSINESS WIRE)--Vizient® today announced its updated analysis of the financial impact…